Sea King Biological Clarification Bulletin: no influenza A (H1N1) vaccine has been produced yet

Sea King Biology (000078) a clarification bulletin says that Haiwing Intron is currently applying for the production of a swine flu vaccine and has not yet made a swine flu vaccine　　, the State Key laboratory of new infectious Diseases of the University of Hong Kong, led by Wang Yingtorong and Professor Virologist, is in the process of consultation on the variation of influenza virus and the study of the strains used in vaccine production and the cooperation for the project, but no agreement has been signed. Haiwing Intron expects to be able to get a swine flu vaccine production next week, and began to transform the existing 1 million-person vaccine production workshop, after the renovation of the production workshop through GMP certification, Haiwing Intron will start production of swine flu vaccine, Capacity is expected to be between 1 million and 2 million people. The process takes 6-8 to six months, but the final production time also depends on the approval of the FDA. Haiwing Intron's 10 million-person vaccine production base does not have a swine flu vaccine production plan.　　The company will be based on Haiwing Intron and the State Key laboratory of cooperation to discuss progress, Haiwing Intron on the production of Influenza A (H1N1) vaccine preparation, timely release information bulletin. In addition, the company denied that Haiwing Intron has now invested 300 million yuan in the bright new zone to build a vaccine production base rumors. The announcement said that Haiwang long into the bright new area vaccine production base of the project construction funds of about 170 million yuan, the current production base of the project has been basically completed, is in the preparation stage of the application for GMP certification.　　According to the JV execution contract, the construction project is part of the capital invested by Hai Wang Yingtorong in the JV company. As Haiwing Intron and GSK have reached the JV execution contract, Haiwing Intron will not be able to carry out new inputs to the vaccine production base, and future work on the vaccine production base, related GMP certification, and production preparation will be transferred to the JV company. (Xing Bai Ying)